Karen A. Flynn
Independent DirectorMs. Karen A. Flynn is Director of Ascend Gene and Cell Therapies LLC. She is Director of Ascend Gene & Cell Therapies Ltd. from 2025. Ms. Flynn serves as Independent Director of Stevanato Group S.p.A.since 2024 and also served as Director of Stevanato Group S.p.A. from May 22, 2024 until 2024. Ms. Flynn is Independent Non-Executive Director at Germfree Laboratories, Inc. from February 2024. She serves as Independent Director at Sotera Health Company since November 2023. She was Director of Catalent Pharma Solutions, Inc. since September 2022 until January 2024. She serves as a Director at Ascend Advanced Therapeutics Ltd. since May 2025. She served as Interim President, Division Head for BioModalities from April 2023 until the end of September 2023. She is an Independent Director at Quanterix Corporation from June 03, 2022. She had been Chief Commercial Officer at Catalent, Inc. since 2021 until July 1, 2022 and served as its Senior Vice President since June 2022 until July 1, 2022. She serves on the Board of the Franklin Institute and previously served on the Chester County Economic Development Council and the Advisory Board of the Downingtown STEM Academy. She previously served on the boards of Recro Pharmaceuticals (NASDAQ:SCTL) from September 2015 to January 2020. She has joined Catalent, Inc. in 2020 and served as its Director since September 15, 2022 until January 25, 2024. Ms. Flynn had been President of Biologics and Chief Commercial Officer at Catalent, Inc. since January 2020 until October 2021. She served as President of Biologics and is Chief Commercial Officer at Catalent Pharma Solutions, Inc. since 2020 and aslo served as its Senior Vice President until July 2022. She had been Chief Commercial Officer and Senior Vice President at West Pharmaceutical Services, Inc. since January 2016 until December 31, 2019. Ms. Flynn served as an Independent Director of Recro Pharma, Inc. since September 3, 2015 until January 6, 2020. Ms. Flynn served as the President of The Pharmaceutical Packaging Systems Business at West Pharmaceutical Services, Inc. since October 2014 until January 2016. Ms. Flynn is responsible for the West largest division. Ms. Flynn served as the President of America's Region of West Pharmaceutical Services, Inc. until October 2014. Ms. Flynn President of Pharmaceutical Packaging Systems Americas Region at West Pharmaceutical Services, Inc. from June 2012 to October 7, 2014, where she was responsible for both the manufacturing and commercial aspects of the business, including management of finance, operations, supply chain, sales, marketing, quality, research and development and human resources. She served as Vice President of Sales at West Pharmaceutical from May 2008 to June 2012. From 2000 to 2008, Ms. Flynn has an extensive background in commercial strategy, strategic planning and innovation and quality management. Ms. Flynn is an accomplished healthcare leader with over 35 years of commercial, operations and general management experience in the pharmaceutical services industry. Ms. Flynn served at Catalent, formerly known as Cardinal Health, where she served in Sales Management, finishing her career there as Vice President, Global Accounts. Prior to Catalent, she served at West, in numerous roles spanning general management, commercial operations, business development, product launch preparation and finance. She is a Member of the Healthcare Businesswomens Association, the Forum of Executive Women and serves on the Downingtown STEM Academy Advisory Board. Ms. Flynn has completed the Womens Senior Leadership Program and the Corporate Governance, Effectiveness and Accountability in the Board Room Program at Kellogg School of Management at Northwestern University and has been an active leader in the EcSell Institute Advisory Board, the Forum of Executive Women, the Healthcare Businesswomens Association and the Advisory Board for Downingtown STEM Academy. She has also received numerous awards, including the Silver Stevie Award for Women in Business and the Ellen Ann Roberts Business Award. Ms. Flynn holds a Bachelor of Science in Pre-Professional Studies from The University of Notre Dame, a Master of Science in Business Administration from Boston University and a Master of Science in Engineering from The University of Pennsylvania.
Positions
- Company NameQuanterix CorporationStock CodeQTRXPositionIndependent DirectorColleagues
- WPWilliam P. DonnellyExecutive Chair
- DRDavid R. WaltCo-Founder & Chairman of Scientific Advisory Board
- JGJames GuteChief Commercial Officer, Interim President & Interim CEO
- JGJames GuteChief Commercial Officer, Interim CEO & Interim President
- JFJason FaesslerCFO & Treasurer
- KAKaren A. FlynnIndependent Director
- JTJeffrey T. ElliottLead Independent Director
- IMIvana Magovcevic-LiebischIndependent Director
- Company NameStevanato Group S.p.A.Stock CodeSTVNPositionIndependent DirectorColleagues
- FSFranco StevanatoCEO & Executive Chairman
- MDMarco Dal LagoChief Financial Officer
- LMLisa MilesChief Communications & Investor Relations Officer
- CCCarla CostaChief Human Resources Officer
- MSMauro StocchiChief Business Strategy Officer
- SSSergio StevanatoEmeritus Chairman
- MBMadhavan BalachandranIndependent Director
- WJWilliam J. FedericiIndependent Director
